18:25 01/14/2026 Current status of Maunja’s new product for obesity.jpg 0 (0) If an oral medication priced at 220,000 won per month is approved in the U.S., it will be launched simultaneously in multiple countries. 0 https://n.news.naver.com/article/008/0005304552 https://n.news.naver.com/article/008/0005304552 How useful was this post? Click on a star to rate it! Submit Rating Average rating 0 / 5. Vote count: 0 No votes so far! Be the first to rate this post.